111313 ⎘
ssRNA viruses positive-sense; Details; Flaviviridae; Flavivirus, e.g. yellow fever virus, dengue, JEV Viruses as such, e.g. new isolates, mutants or their genomic sequences
INFECTIOUS FULL-LENGTH CLONE OF ZIKA VIRUS OR VARIANT THEREOF AND USE THEREOF
#2SELF-AMPLIFYING mRNA VACCINE BASED ON Z7 GENOME
#3VACCINES AGAINST INFECTIOUS DISEASES CAUSED BY POSITIVE STRANDED RNA VIRUSES
#4HIGH-TITER JAPANESE ENCEPHALITIS VIRUS GENOTYPE 5 AND USES THEREOF
#5FORMULATIONS OF ANTIBODY MOLECULES TO DENGUE VIRUS
#6OLIGOMERIZATION PARTICLE FORMATION FUSION PROTEIN WITH IMMUNOGENIC ANTIGEN
#7A CLOSED-SYSTEM UPSTREAM MANUFACTURING PROCESS FOR DENGUE VIRUS PRODUCTION
#8Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses
#9METHOD OF PRODUCING MODIFIED VIRUS GENOMES AND PRODUCING MODIFIED VIRUSES
#10MODIFIED GENOMES AND USE THEREOF
#11Stable Reporter Flavivirus
#12ATTENUATED DENGUE VIRUSES
#13Method of detecting antibodies against JEV or ZIKV using recombinant baculoviruses expressing prM/e
#14Attenuated virus mutated at sites of evolutionarily conserved RNA structure
#15Method for treating cancer using dengue virus serotype 1 (DENV-1)
#16Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses
#17Rapid method of generating live attenuated vaccines
#18Chimeric viruses encoding mutant zika virus envelope glycoproteins
#19Zika virus strains for treatment of glioma
#20Chimeric insect-specific flaviviruses
#21Attenuated flaviviruses
#22Methods for detection of flavivirus antibodies
#23Live-attenuated flaviruses with heterologous antigens
#24Chimeric yellow fever ZIKA virus strain
#25Formulations of antibody molecules to dengue virus
#26COMPOSITIONS AND METHODS FOR CANCER THERAPY WITH DENGUE VIRUS AND DENDRITIC CELLS
#27Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein
#28COMPOSITIONS AND METHODS FOR THERAPY WITH DENGUE VIRUS
#29Addition of nucleases directly to cell culture to facilitate digestion and clearance of host cell nucleic acids
#30Viral synthetic nucleic acid sequences and use thereof
#31Vaccines against infectious diseases caused by positive stranded RNA viruses
#32Zika virus vaccine
#33Vaccine compositions comprising an attenuated mutant Zika virus
#34Compositions, methods and uses for dengue virus serotype-4 constructs
#35Recombinant Zika vaccines
#36Immune enhancing recombinant dengue protein
#37Attenuated virus having multiple hosts
#38Chromatography based purification strategies for viruses
#39Multivalent dengue vaccine composition comprising a mixture of attenuated dengue viruses from different serotypes
#40CDNA clone-launched platform for high-yield production of inactivated zika virus
#41Attenuated virus mutated at sites of evolutionarily conserved RNA structure
#42Vaccine combination against multiple dengue virus serotypes and preparation and application thereof
#43Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
#44Compositions, methods and uses for dengue virus serotype-4 constructs
#45Immune enhancing recombinant dengue protein
#46Compositions and methods for combination therapy with dengue virus and dendritic cells
#47Avirulent, immunogenic flavivirus chimeras
#48Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped RNA viruses
#49Dengue virus vaccine composition
#50NOVEL ATTENUATED DENGUE VIRUS STRAINS FOR VACCINE APPLICATION
#51Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein
#52Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses
#53High yield yellow fever virus strain with increased propagation in cells
#54Neurovirulent strain of the West Nile virus and uses thereof
#55Compositions, methods and uses for dengue virus serotype-4 constructs
#56Replication-defective flavivirus vaccines and vaccine vectors
#57Neurovirulent strain of the West Nile virus and uses thereof
#58COMPOSITIONS COMPRISING IMMUNOSTIMULATORY NUCLEIC ACIDS AND RELATED METHODS
#59Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region
#60Dengue serotype 1 attenuated strain
#61Avirulent, immunogenic flavivirus chimeras
#62High yield yellow fever virus strain with increased propagation in cells
#63Dengue chimeric viruses
#64Replication-defective flavivirus vaccines and vaccine vectors
#65Recombinant bicistronic flaviviruses and methods of use thereof
#66Avirulent, immunogenic flavivirus chimeras
#67Dengue chimeric viruses
#68Dengue serotype 1 attenuated strain
#69NEUROVIRULENT STRAIN OF THE WEST NILE VIRUS AND USES THEREOF
#70Two-component genome flavivirus and uses thereof
#71Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis
#72Avirulent, immunogenic flavivirus chimeras
#73Dengue virus mutant strain MBU 01-2002
#74Attenuated dengue virus comprising mutations in the NS3 gene
#75Dengue serotype 1 attenuated strain
#76Full-length genomic RNA of Japanese encephalitis virus, infectious JEV cDNA therefrom, and use thereof
#77Avirulent, immunogenic flavivirus chimeras
#78Neurovirulent strain of the West Nile virus and uses thereof
#79Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses